{"entity":{"type":"insider","cik":"0001993522","url":"/insider/0001993522","json_url":"/insider/0001993522.json","name":"Viking Global Opportunities Drawdown Portfolio GP LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":1,"first":"2023-09-21","last":"2023-09-21","span_basis":"filed_date"},"name_variants":[{"name":"Viking Global Opportunities Drawdown Portfolio GP LLC","source":"filing","n_filings":1,"first_seen":"2023-09-21","last_seen":"2023-09-21"}],"transactions":[{"id":8213557,"accession":"0000905148-23-000959","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000905148-23-000959","line_url":"/filing/0000905148-23-000959#line-6","is_derivative":false,"issuer_cik":"0001103804","issuer_name":"RayzeBio, Inc.","issuer_ticker":"RYZB","issuer_name_source":null,"issuer_url":"/issuer/0001103804","owner_cik":null,"owner_name":"HALVORSEN OLE ANDREAS; Ott David C.; Shabet Rose Sharon; VIKING GLOBAL INVESTORS LP; Viking Global Opportunities Drawdown (Aggregator) LP; Viking Global Opportunities Drawdown GP LLC; Viking Global Opportunities Drawdown Portfolio GP LLC; Viking Global Opportunities Parent GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":930556.0,"shares_display":"930,556","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":16750008.0,"total_display":"16,750,008.00","shares_owned_after":4899144.0,"shares_owned_after_display":"4,899,144","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":8213556,"accession":"0000905148-23-000959","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000905148-23-000959","line_url":"/filing/0000905148-23-000959#line-5","is_derivative":false,"issuer_cik":"0001103804","issuer_name":"RayzeBio, Inc.","issuer_ticker":"RYZB","issuer_name_source":null,"issuer_url":"/issuer/0001103804","owner_cik":null,"owner_name":"HALVORSEN OLE ANDREAS; Ott David C.; Shabet Rose Sharon; VIKING GLOBAL INVESTORS LP; Viking Global Opportunities Drawdown (Aggregator) LP; Viking Global Opportunities Drawdown GP LLC; Viking Global Opportunities Drawdown Portfolio GP LLC; Viking Global Opportunities Parent GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":458333.0,"shares_display":"458,333","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":8249994.0,"total_display":"8,249,994.00","shares_owned_after":1743556.0,"shares_owned_after_display":"1,743,556","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001825367","name":"RayzeBio, Inc.","url":"/issuer/0001825367","role":"Ten percent owner","n_filings":1,"first_seen":"2023-09-21","last_seen":"2023-09-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001993522","retrieved_at":"2026-08-21T18:31:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}